✦ LIBER ✦

PDB11 RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH DIABETES TREATED WITH EXENATIDE OR THIAZOLIDINEDIONES: A RETROSPECTIVE ANALYSIS OF THE PHARMETRICS DATABASE

✍ Scribed by JH Best; E Pelletier; BJ Hoogwerf; WH Herman; MB DeYoung; DB Smith; I Yushmanova; M Hussein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB25 COST OF ALL-CAUSE AND CARDIOVASCUL

✍ J.H. Best; E. Pelletier; D.B. Smith 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PDB10 Achieving Target Goals in Patients

✍ Bruhn, D.; Han, J.; Meloni, A.; DeYoung, M.B.; Anderson, P.W. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PDB11 Glycemic Outcomes Among Patients R

✍ Best, J.H.; Wintle, M.; Saunders, W.B.; DeYoung, M.B.; Blickensderfer, A.; Maggs 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Effects of Thiazolidinediones on Cardiov

✍ Hsien-Tsung Yeh; Chi-Feng Hsieh; Yi-Wen Tsai; Weng-Foung Huang 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Cardiovascular events among 1090 cancer

✍ Ewer, Michael S.; Suter, Thomas M.; Lenihan, Daniel J.; Niculescu, Liviu; Breazn 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 741 KB

Reduction in Estimated 10-Year Coronary

✍ Elaine Chiquette; Gilbert Ramirez; Peter P. Toth; Michael Cobble; Brandon Walsh; 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 66 KB